Healthcare Services

Organoids Market Forecast 2026–2035 Highlighting Market Data Patterns and Industry Insights

April 3, 2026April 6, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Much Is The Organoids Market Expected To Grow In Terms Of Market Value Between 2026 And 2030?

The organoids market has witnessed substantial expansion over recent years. Forecasts indicate it will expand from $4.82 billion in 2025 to reach $5.9 billion by 2026, exhibiting a compound annual growth rate (CAGR) of 22.3%. Historically, this expansion has been driven by several factors, including breakthroughs in stem cell technology, an escalating need for alternatives to animal testing, intensified research in tissue engineering, increased funding for biotechnology research and development, and the swift incorporation of organoid models by academic research institutions.

The organoids market is projected to experience substantial growth in the coming years, reaching $13.13 billion by 2030, driven by a compound annual growth rate (CAGR) of 22.2%. This expansion during the forecast period is fueled by several factors, including the broadening of personalized medicine applications, a rise in collaborations between the pharmaceutical industry and organoid research firms, an increase in regenerative medicine initiatives, enhanced government and private investment in organoid-based research, and the establishment of organoid biobanks for disease modeling purposes. Key trends anticipated during this period involve the increasing integration of organoids in drug discovery and personalized medicine, their expanding utility in regenerative medicine and tissue engineering, a surge in their application for infectious disease pathology studies, the accelerated development of disease-specific organoids for targeted therapeutic approaches, and their greater incorporation into preclinical drug efficacy and toxicity assessments.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10787&type=smp

Which Growth Drivers Are Contributing To The Progress Of The Organoids Market?

The organoid market is anticipated to experience growth due to the escalating incidence and prevalence of chronic and infectious diseases. A chronic disease is characterized as a condition lasting over a year and necessitating ongoing medical treatment. Organoids have proven useful in studying various chronic diseases and their therapies by providing immediate and dependable information regarding pathogen biology and drug screening. Consequently, the increase in the incidence and prevalence of chronic and infectious diseases will bolster the organoid market. For instance, in June 2024, data from the National Health Service, a UK-based publicly funded healthcare system, indicated that 3,615,330 individuals registered with a GP were found to have non-diabetic hyperglycemia, also known as pre-diabetes, in 2023. This figure represents an 18% increase compared to 3,065,825 in 2022. Therefore, the rising prevalence of chronic diseases is set to drive the organoids market.

What Major Segment Divisions Exist Within The Organoids Market?

The organoids market covered in this report is segmented –

1) By Product: Hepatic Organoid, Colorectal Organoid, Intestinal Organoid, Other Products

2) By Application: Developmental Biology, Disease Pathology Of Infectious Disease, Regenerative Medicine, Drug Toxicity And Efficacy Testing, Drug Discovery And Personalized Medicine, Other Applications

3) By End-User: Hospitals And Diagnostic Centers, Biotechnology And Pharmaceutical Companies, Other End-Users

Subsegments:

1) By Hepatic Organoid: Hepatic Stem Cell-Derived Organoids, Primary Liver Cell-Derived Organoids, Liver Tumor Organoids

2) By Colorectal Organoid: Colonic Organoids, Rectal Organoids, Colorectal Cancer Organoids

3) By Intestinal Organoid: Small Intestinal Organoids, Enteroid Organoids, Intestinal Stem Cell-Derived Organoids

4) By Other Products: Pancreatic Organoids, Brain Organoids, Kidney Organoids, Lung Organoids

What Trends Are Advancing Progress In The Organoids Market?

Leading firms within the organoids market are prioritizing the creation of innovative platforms, including organoid panel screening platforms, with the goal of expediting preclinical oncology drug discovery and securing a market advantage. Such a platform is defined as a system designed to facilitate the screening of multiple organoids concurrently. A relevant example is Crown Bioscience, a US-based contract research organization (CRO) and a JSR Life Sciences company, which introduced OrganoidXplore in November 2023. This marks a groundbreaking large-scale organoid panel screening platform aimed at speeding up preclinical oncology drug discovery. The OrganoidXplore platform employs Crown Bioscience’s proprietary assay-ready (AR) organoid technology, delivering highly reliable performance, faster project completion, and lower expenses compared to conventional approaches. OrganoidXplore enables dependable and consistent comparisons of drug responses, representing a major leap forward in preclinical drug screening because it precisely mimics the genomic, morphological, and pathophysiological characteristics of primary tumors.

Which Companies Are Leading Innovation In The Organoids Market?

Major companies operating in the organoids market are Cellesce Ltd., STEMCELL Technologies, HUB Organoids, DefiniGEN, OcellO B.V., Organoid Therapeutics, InSphero AG, Axol Bioscience Ltd., TissUse GmbH, Epithelix Sàrl, SUN Bioscience, Prellis Biologics, Epistem, MIMETAS BV, Organoidsciences Ltd., Zenit Science, Biomorgan, TheWell Bioscience Inc., CN Bio Innovations Ltd., TARA Biosystems, Nortis Inc., Newcells Biotech, Known Medicine, Dynomics Inc., CHA Biotech Co Ltd, Tempus AI Inc.

Read the full organoids market report here:

https://www.thebusinessresearchcompany.com/report/organoids-global-market-report

What Are The Leading Geographic Regions In The Organoids Market?

North America was the largest region in the organoids market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global organoids market size forecast period. The regions covered in the organoids market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Organoids Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=10787&type=smp

Browse Through More Reports Similar to the Global Organoids Market 2026, By The Business Research Company

Polyurethane Foam Global Market Report

https://www.thebusinessresearchcompany.com/report/polyurethane-foam-global-market-report

Structural Insulated Panels Market

https://www.thebusinessresearchcompany.com/report/structural-insulated-panels-market

Polyurethane Foam Mattress Global Market Report

https://www.thebusinessresearchcompany.com/report/polyurethane-foam-mattress-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795